Evotec SE (EVO) Cash from Operations (2009 - 2026)
Evotec SE's (EVO) quarterly Cash from Operations came in at -$4.6 million in Q1 2026, up 86.3% year-over-year from -$2.5 million in Q1 2025, and up 25.01% quarter-over-quarter from -$6.1 million in Q4 2025.
Analysis
Evotec SE (EVO) Cash from Operations (2009 - 2026) Analysis & Trends
Evotec SE has disclosed Cash from Operations across 9 years of filings, most recently posting -$4.6 million for Q1 2026.
- In Q1 2026, Cash from Operations rose 86.3% year-over-year to -$4.6 million; the TTM figure through Mar 2026 stood at -$59.6 million (down 255.5% YoY), while the FY2025 annual figure was -$10.4 million, down 152.59% from the prior year.
- Cash from Operations came in at -$4.6 million for Q1 2026 at Evotec SE, up from -$6.1 million in the prior quarter.
- In the past five years, Cash from Operations ranged from a high of $188.9 million in Q2 2022 to a low of -$79.0 million in Q3 2025.
- Average Cash from Operations over 5 years is $10.4 million, with a median of -$4.3 million recorded in 2022.
- Year-over-year, Cash from Operations jumped 2407103.0% in 2022 and sank 7889.36% in 2024.
- Over 5 years, Cash from Operations stood at -$31.4 million in 2022, then surged by 168.24% to $21.5 million in 2023, then surged by 269.6% to $79.3 million in 2024, then plunged by 107.71% to -$6.1 million in 2025, then grew by 25.01% to -$4.6 million in 2026.
- Per Business Quant data, the three most recent Cash from Operations figures were -$4.6 million in Q1 2026, -$6.1 million in Q4 2025, and -$79.0 million in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Iqvia Holdings | 44.72 Bn | 42.64 Bn | 1.44 Bn | 558.00 Mn |
| 2 | Medpace Holdings | 17.37 Bn | 16.87 Bn | 201.64 Mn | 162.01 Mn |
| 3 | Icon | 13.65 Bn | 12.72 Bn | 479.29 Mn | 281.27 Mn |
| 4 | Charles River Laboratories International | 13.13 Bn | 12.94 Bn | 452.07 Mn | 179.73 Mn |
| 5 | Fortrea Holdings | 1.89 Bn | 1.72 Bn | 139.20 Mn | 28.90 Mn |
| 6 | Evotec SE | 574.75 Mn | 148.87 Mn | - | - |
| 7 | Ginkgo Bioworks Holdings | 439.63 Mn | 355.09 Mn | 18.44 Mn | -44.27 Mn |
| 8 | Champions Oncology | 69.43 Mn | 65.03 Mn | 7.70 Mn | -492,000.00 |
| 9 | MindWalk Holdings | 51.76 Mn | 46.29 Mn | 1.61 Mn | -2.90 Mn |
| 10 | VivoSim Labs | 1.37 Mn | 1.37 Mn | - | -3.21 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | -4.58 Mn |
| Dec 31, 2025 | -6.11 Mn |
| Sep 30, 2025 | -78.98 Mn |
| Jun 30, 2025 | 30.06 Mn |
| Mar 31, 2025 | -33.46 Mn |
| Dec 31, 2024 | 79.31 Mn |
| Sep 30, 2024 | 46.78 Mn |
| Jun 30, 2024 | -54.30 Mn |
| Mar 31, 2024 | -52.34 Mn |
| Dec 31, 2023 | 21.46 Mn |
| Jun 30, 2023 | -6.75 Mn |
| Mar 31, 2023 | 671,911.98 |
| Dec 31, 2022 | -31.45 Mn |
| Sep 30, 2022 | -4.01 Mn |
| Jun 30, 2022 | 188.86 Mn |
| Mar 31, 2022 | 71.40 Mn |
| Dec 31, 2021 | 74.01 Mn |
| Sep 30, 2021 | 24.53 Mn |
| Jun 30, 2021 | 49.50 Mn |
| Mar 31, 2021 | 2,966.13 |